An internationally renowned avian influenza expert hailed “encouraging and exciting” results from experiments conducted by his research team. This study demonstrated impressive efficacy of a novel statin/caffeine combination, StatC™ in the treatment and prevention of H5N1, H1N1 and H3N2 in a mouse model. Dr.
Share and Enjoy:
These icons link to social bookmarking […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Densely populated cities and increased air travel can be factors which create and spread pandemic disease. But a McMaster University researcher is working with isolated Hutterite communities to understand the transmission of pandemic diseases like influenza. Dr. Mark Loeb and his research team have received $1.
Share and Enjoy:
These icons link to […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
A strain of Highly Pathogenic Avian Influenza previously not recorded in sub-Saharan Africa has been detected in Nigeria for the first time, FAO said recently. Nigeria has recently reported two new Highly Pathogenic Avian Influenza outbreaks in the states of Katsina and Kano.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
An influential Lords Committee have today reported that a new and potentially deadly infectious disease emerges somewhere in the world every year and it is vital that there is more investment in international surveillance if pandemics are to be avoided.
Share and Enjoy:
These icons link to social bookmarking sites where readers can […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced recently pre-clinical results from two proprietary plasmid DNA-based universal influenza vaccine candidates using the company’s proprietary electroporation delivery technology and, specifically, a new intradermal device.
Share and Enjoy:
These icons link to social bookmarking sites where […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Vical Incorporated (Nasdaq: VICL) announced a breakthrough with preliminary clinical trial data demonstrating that DNA vaccines can safely achieve significant immune responses against H5N1 pandemic influenza in humans.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Information relevant to Indiana’s current pandemic influenza preparedness plan was presented July 16 during a symposium convened by the Indiana State Department of Health and the Indiana University Center for Bioethics, “The Ethics of Pandemic Influenza Planning in Indiana: What Have We Done and
Share and Enjoy:
These icons link to social bookmarking sites where readers can […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Scientists and researchers have taken a big step closer to a cure for the most common strain of avian influenza, or “bird flu,” the potential pandemic that has claimed more than 200 lives and infected nearly 400 people in 14 countries since it was identified in 2003. Researchers at the U.S.
Share and […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
New evidence suggests that a booster vaccination against H5N1 avian influenza given years after initial vaccination with a different strain may prove useful in controlling a potential future pandemic. The study is published in the August 1 issue of The Journal of Infectious Diseases, now available online. H5N1 continues to pose a […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...
Vical Incorporated (Nasdaq: VICL) announced the scheduled presentation of preliminary human safety and immunogenicity data from a Phase 1 trial of the company’s Vaxfectin(R)-formulated H5N1 pandemic influenza DNA vaccines on Thursday, July 17, at the IBC […]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read the full article...